BackgroundMetformin is the first-line oral hypoglycemic agent for type 2 diabetes mellitus recommended by international guidelines. However, little information exists comparing it with acarbose which

Figshare2016-01-15 更新00

Number of included patients, mean difference and heterogeneity in meta-analyses of double blind, randomised controlled trials comparing SGLT2-i versus oral antidiabetic drugs.

糖尿病药物比较

临床荟萃分析

Number of included patients, mean difference and heterogeneity in meta-analyses of double blind, randomised controlled trials comparing SGLT2-i versus oral antidiabetic drugs.

NIAID Data Ecosystem20

Available IPD datapackage for study 'A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Subjects With Type 2 Diabetes'

糖尿病药物比较

糖尿病治疗

The purpose of this study is to evaluate the efficacy and safety of alogliptin, once daily (QD), compared to glipizide in elderly diabetic patients who have not received treatment or are on a single o

DataCite Commons2024-12-02 更新00

The cumulative rate of event in difference drug in diabetes patients.

资源简介：

相关数据集